enGene Therapeutics Inc. Common Stock (NASDAQ: ENGN) last traded at $1.78, up 0.56% on the session. The quote above updates while this page is open; the figures below are drawn from enGene Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
enGene Therapeutics Inc. Common Stock trades on NASDAQ under the ticker ENGN. Its market capitalisation is $119.24 million.
Valuation measures for enGene Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $119.24M |
|---|---|
| Enterprise value | $141.77M |
| P/E ratio | 0.76 |
| Price / book | 0.47 |
| Beta | 2.20 |
Trailing-twelve-month figures tagged in enGene Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$126.85M |
|---|---|
| EPS (TTM) | $2.33 |
| Return on equity | -49.71% |
| Cash | $29.83M |
Range and volume for ENGN over the past 52 weeks.
| 52-week high | $12.25 |
|---|---|
| 52-week low | $1.40 |
| Volume | 241.4K |
| Average volume | 924.7K |
| Previous close | $1.77 |
Dividend history for enGene Therapeutics Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
| Payout ratio | 0.00% |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.